5-hydroxymethyl-2'-deoxyuridine has been researched along with olaparib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bajrami, I; Boulton, SJ; Carell, T; Fugger, K; Goldstone, R; Hewitt, G; Kelly, G; Kunzelmann, S; MacRae, J; Patel, H; Silva Dos Santos, M; Taylor, IA; West, SC; Young, SJ | 1 |
1 other study(ies) available for 5-hydroxymethyl-2'-deoxyuridine and olaparib
Article | Year |
---|---|
Targeting the nucleotide salvage factor DNPH1 sensitizes
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; CRISPR-Cas Systems; Deoxycytidine Monophosphate; Deoxyuracil Nucleotides; DNA Breaks, Double-Stranded; DNA Replication; DNA, Neoplasm; Drug Resistance, Neoplasm; Genes, BRCA1; Humans; Hydrolysis; N-Glycosyl Hydrolases; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins; Synthetic Lethal Mutations; Thymidine; Uracil-DNA Glycosidase | 2021 |